Fund Holdings — Nan Fung Group Holdings Ltd

Total Portfolio Value:
$131.49M
Total Bought:
$8.38M
Total Sold:
$8.37M
Net Transaction:
+$9.4K
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
MAPLIGHT THERAPEUTICS INC971,253971,2530$19.75M$34.81M26.47%+$15.06M
LB Pharmaceuticals Inc(LBRX)630,657630,6570$15.55M$20.47M15.57%+$4.92M
EVOMMUNE INC1,441,0321,441,0320$33.13M$19.15M14.56%-$13.98M
CYBIN INC460,000987,222+527,222$2.21M$6.53M4.96%+$4.32M
Incyte Corporation(INCY)53,74253,7420$5.06M$6.09M4.63%+$1.03M
Rhythm Pharmaceuticals, Inc.(RYTM)49,12049,1200$4.27M$5.45M4.15%+$1.18M
BeOne Medicines AG(ONC)15,72215,7220$4.67M$4.48M3.41%-$188.7K
OCULIS HOLDING AG350,745300,565-50,180$9.33M$4.17M3.17%-$5.16M
Ascendis Pharma A/S(ASND)013,600+13,600$0$3.63M2.76%+$3.63M
Revolution Medicines, Inc.(RVMD)19,25319,2530$1.87M$3.61M2.74%+$1.73M
Kymera Therapeutics, Inc.(KYMR)30,87530,8750$2.57M$3.54M2.69%+$968.9K
Madrigal Pharmaceuticals, Inc.(MDGL)5,6725,6720$2.97M$3.05M2.32%+$76.5K
Celcuity Inc.(CELC)28,30028,3000$3.23M$2.96M2.25%-$269.4K
ACADIA PHARMACEUTICALS INC102,984102,9840$2.29M$2.61M1.98%+$313.1K
argenx SE(ARGX)2,8002,8000$2.04M$2.60M1.98%+$553.1K
Recursion Pharmaceuticals, Inc.(RXRX)595,287595,2870$1.83M$2.18M1.66%+$357.2K
Procore Technologies, Inc.(PCOR)53,29953,2990$3.04M$2.17M1.65%-$873.0K
Harmony Biosciences Holdings, Inc.(HRMY)27,04927,0490$757.6K$984.9K0.75%+$227.2K
Insmed Incorporated(INSM)6,5806,5800$1.08M$701.6K0.53%-$374.4K
iShares Ethereum Trust ETF(ETHA)50,54950,5490$800.2K$601.0K0.46%-$199.2K
iShares Bitcoin Trust ETF(IBIT)15,96815,9680$613.5K$531.6K0.40%-$81.9K
Chime Financial, Inc.(CHYM)021,075+21,075$0$431.6K0.33%+$431.6K
RANI THERAPEUTICS HLDGS INC493,584493,5840$362.7K$375.3K0.29%+$12.6K
ENTRADA THERAPEUTICS INC49,08249,0820$619.4K$361.2K0.27%-$258.2K
BOLT BIOTHERAPEUTICS INC29,2505,000-24,250$118.2K$19.3K0.01%-$98.9K
Ascendis Pharma A/S(ASND)13,6000-13,600$3.11M$0—-$3.11M
Page 1 of 1
Nan Fung Group Holdings Ltd — 13F Holdings — Q2 2026 | TickerTrail